NNN — Nanosynth Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Annual cashflow statement for Nanosynth, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.
R2017 December 31st | R2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -2.23 | -0.775 | -0.592 | -1.53 | -3.18 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 0.6 | -0.149 | -0.655 | 0.767 | 0.871 |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.374 | -0.015 | 0.248 | -0.245 | -0.028 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -1.57 | -0.543 | -0.583 | -0.99 | -2.32 |
| Capital Expenditures | -0.056 | -0.536 | -0.038 | -0.001 | -0.038 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.011 | -0.108 | 0.03 | 0.176 | -0.044 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.045 | -0.644 | -0.008 | 0.175 | -0.081 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 2.11 | 0.793 | 0.556 | 4.48 | 2.42 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.501 | -0.394 | -0.035 | 3.67 | 0.02 |